Competency in oncology:

The Thoracic Tumors team offers the latest options in systemic therapy and multimodal methodologies to care about 4,800 patients with malignant chest tumors annually. The department is a recognized driving factor in the design and implementation of clinical clinical trials to improve holistic treatment, and it provides personalized treatment methodologies to suit each individual patient, which are adjusted according to the nature of the tumor and physiology. (All chest and medical cases (chest cage) / mega-cell lung cancer / small-cell lung cancer / pancoast tumor / thymus cancer / peri-membrane tumor / lung sarcomas / lung metastases for all malignant cases)